Purpose: The growing use of social media has increased access to online health and nutrition information, which may influence individuals’ eating behaviors. This study examined the relationship between digital healthy diet literacy, social media addiction, and eating behaviors among adults. Methods: This cross-sectional study included 554 adults aged 18–64 years in Kırklareli, Türkiye. Data were collected through face-to-face interviews using a Personal Information Form, the Social Media Addiction Scale (SESMEB), the Bergen Social Media Addiction Scale (BSMAS), and the Digital Healthy Diet Literacy Scale (DHDL). Anthropometric measurements were obtained by the researchers. Results: The participants’ mean age was 31.5 ± 10.4 years; 52% were female and 43.5% university graduates. SESMEB and BSMAS scores were higher among younger, single, and more educated individuals but lower among obese participants ( p < 0.05). DHDL scores were higher in those with higher education, regular exercise, and sufficient income, but lower in obese participants ( p < 0.05). Significant relationships were found between all scales and social media use characteristics (number of accounts, duration, importance of likes, participation in nutrition groups, and exposure to advertisements). Strong positive correlations were observed among SESMEB, BSMAS, and DHDL scores. Conclusions: Social media addiction and digital healthy diet literacy are inter-related and may influence eating behaviors. Enhancing digital health and nutrition literacy may help reduce negative effects of social media and promote healthier eating habits. Level of evidence : Level III, cross-sectional analytic study.

Background and Objectives: This study aimed to evaluate the impact of myoinositol (MYO) and α-lipoic acid (ALA) supplementation on hormonal and metabolic markers in women diagnosed with polycystic ovary syndrome (PCOS). Materials and Methods: A retrospective case–control study was conducted with 58 women aged between 18–40 years who met the Rotterdam criteria for PCOS. The case group (n = 29) received MYO (2000 mg/day) and ALA (400 mg/day) supplements, while the control group (n = 29) did not receive any treatment. Data on the subjects’ anthropometric measures, glycemic indices, sex hormones, and lipid profiles were collected. Results: The results demonstrated that, following three months of MYO + ALA supplementation, the case group exhibited steady body weight (p = 0.484) and BMI (p = 0.405), whereas the control group demonstrated a significant increase in both (p = 0.029; p = 0.026, respectively). A stratified analysis based on BMI, waist circumference, and waist-to-height ratio revealed that HbA1c (%) was significantly lower in the “normal” subgroup compared to the “risky” subgroup within the case group (p < 0.05). Although the mean HbA1c, insulin, and HOMA-IR values were comparable between the two groups, the LH/FSH ratio significantly increased in the control group (p = 0.010). No significant differences were observed in the lipid profiles between the two groups; however, LDL levels decreased significantly in the case group (p = 0.024). Across all classifications, the “normal” subgroup consistently exhibited lower HbA1c and TG/HDL ratios than the “risky” subgroup. Conclusions: Adding MYO + ALA supplementation to standard PCOS treatment may offer metabolic benefits, particularly in maintaining glycemic control, body weight, and BMI. Supplementation also reduces LDL.

Desmoplastic small round cell tumor is a rare sarcoma with 5-year overall survival of 15%. An 8-year-old female presented with diffuse abdominal/pelvic desmoplastic small round cell tumor including numerous liver metastasis. She underwent neoadjuvant chemotherapy followed by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Residual disease was found shortly after CRS/HIPEC which was resected, followed by whole abdomen/pelvic radiation and autologous hematopoietic cell transplant. Previous papers have reported dismal survival in patients with liver metastasis and residual disease arguing against CRS/HIPEC. Our patient remains disease-free over 6 years after completing therapy indicating long-term survival is achievable with aggressive multimodal therapy.